ARCHIVES

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Awards $6.7 Million For Breast Cancer Research.

September 8, 2000

NCI Should Enhance Funding Of Centers Program, Porter Says

July 12, 1991

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

September 25, 1998

Foon Moves To UPCI

April 18, 2003

Letter to the Editors: Scientists, Media Shouldn’t Overstate “Breakthroughs”

May 29, 1998